Form 4: Core Scientific Director Booth Receives RSU Grant

Core Scientific Director Jeffrey David Booth was granted 18,575 restricted stock units, vesting in February 2027.

Summary

• Jeffrey David Booth, a Director at Core Scientific, Inc. (CORZ), acquired 18,575 restricted stock units (RSUs).
• The transaction date for the RSU grant was February 4, 2026.
• The RSUs were granted at a price of $0.
• Following this transaction, Booth beneficially owns 214,262 shares of common stock.
• The RSUs will vest in full on February 3, 2027, provided Booth continues to serve as a non-employee director.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting continued director commitment and alignment with shareholder interests through equity compensation, which is a standard and healthy practice.

Positives

• The grant of restricted stock units aligns the director's interests with long-term shareholder value, as vesting is contingent on continued service and potential stock price appreciation.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged and transparent acquisition.

Risks

• The vesting of the 18,575 restricted stock units is contingent on Jeffrey David Booth's continued service as a non-employee director to Core Scientific, Inc. until February 3, 2027.

Future Outlook

The vesting schedule for the restricted stock units indicates an expectation for Director Booth to continue his service to Core Scientific until at least February 3, 2027.

Industry Context

StockSavvy.ai notes that equity grants, such as restricted stock units, are a common form of compensation for non-employee directors in the technology and cryptocurrency mining sectors. These grants are designed to incentivize long-term commitment and align director interests with shareholder value, a standard practice across publicly traded companies.

Comparison to Industry Standards

• The grant of RSUs to a non-employee director is a standard compensation practice, comparable to similar grants observed at companies like Marathon Digital Holdings (MARA) or Riot Platforms (RIOT) within the cryptocurrency mining industry, aiming to retain talent and align interests.
• The vesting schedule, tied to continued service, is typical for such equity awards, ensuring the director's commitment over a specified period.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's long-term interests with shareholders, potentially encouraging decisions that enhance stock value.

Next Steps

• The 18,575 restricted stock units are scheduled to vest in full on February 3, 2027.

Key Dates

Recommendation

This Form 4 reports a routine equity grant to an existing director, which is a standard compensation practice. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. It primarily signals continued director commitment, which is a neutral to slightly positive factor, supporting a 'hold' stance for existing investors.

Keywords

Core Scientific, CORZ, Jeffrey David Booth, Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, Beneficial Ownership